Clinical studies recruiting near Bengbu

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · The First Affiliated Hospital of Bengbu Medical College · Huabo Biopharm Co., Ltd. · NCT06592274 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · The First Affiliated Hospital Of Bengbu Medical College · Takeda · NCT06671496 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · The First Affiliated Hospital of Bengbu Medical College · Shanghai Henlius Biotech · NCT07160335 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · The First Affiliated Hospital of Bengbu Medical University · Amgen · NCT07037433 Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective
NA · The First Affiliated Hospital of Bengbu Medical University · Second Affiliated Hospital, Zhejiang University, School of M · NCT07402525 A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Phase 3 · The First Affiliated Hospital Of Bengbu Medical College · argenx · NCT06544499 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Dynamic Airway Resistance & ML: Guide Sputum Suction in Ventilated Patients
NA · The First Affiliated Hospital of Bengbu Medical University · Affiliated Hospital of Nantong University · NCT07375667 Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function
Phase 1 · The First Affiliated Hospital of Bengbu Medical University · Jiangsu vcare pharmaceutical technology co., LTD · NCT07551557 A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL.
Phase 3 · The First Affiliated Hospital of Bengbu Medical College · Ascentage Pharma Group Inc. · NCT06319456 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · The First Afflilated Hospital of Bengbu Medical College · Eli Lilly and Company · NCT07353931 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · The First Affiliated Hospital of Bengbu Medical College · Eli Lilly and Company · NCT06338995 Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic
Phase 2 · Research Site · AstraZeneca · NCT06535607 Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
Phase 3 · The Third The People's Hospital Of Bengbu · Capital Medical University · NCT06548971 A Study of BL-M07D1 With or Without Pertuzumab Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER
Phase 2/Phase 3 · The First Affiliated Hospital of Bengbu Medical University · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06891833 A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Phase 2 · The First Afflilated Hospital of Bengbu Medical College ( Si · Merck Sharp & Dohme LLC · NCT07133633 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carbop
Phase 3 · The First Affiliated Hospital Of Bengbu Medical College · Boehringer Ingelheim · NCT07472517 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
Phase 2 · The First Affiliated Hospital of Bengbu Medical College · Shanghai Pharmaceuticals Holding Co., Ltd · NCT05872347 Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy
Phase 2 · Jing Liu · Yan Yang, MD, Ph.D · NCT04970121 A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esopha
Phase 3 · 135 · MediLink Therapeutics (Suzhou) Co., Ltd. · NCT07487896 A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treat
Phase 3 · Research Site · AstraZeneca · NCT06764875 A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors
Phase 1/Phase 2 · The First Affiliated Hospital of Bengbu Medical University · Shanghai Pharmaceuticals Holding Co., Ltd · NCT06214143 A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL
Phase 3 · The First Affiliated Hospital of Bengbu Medical College · Hutchmed · NCT07409428 A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors
Phase 1/Phase 2 · The Fisrt Affiliated Hospital of Bengbu Medical University · Heronova Pharmaceuticals · NCT06873555 A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.
Phase 1 · The First Affiliated Hospital of Bengbu Medical College · Shanghai Institute Of Biological Products · NCT06298071 Evaluation of the Safety and Effectiveness of CHORDS® Cerebral Protection System During TAVR: DUET Trial
NA · The First Affiliated Hospital of Bengbu Medical College · Resonova (Shanghai) Medtech Limited · NCT07648693 A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors
Phase 1/Phase 2 · The First Affiliated Hospital of Bengbu Medical University · RemeGen Co., Ltd. · NCT06038396 A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate,
Phase 1 · The First Affiliated Hospital of Bengbu Medical University · BeOne Medicines · NCT06625593 Additive Anti-inflammatory Action for Aortopathy & Arteriopathy
Phase N/A · the First Affiliated Hospital of Bengbu Medical College · Nanjing Medical University · NCT04398992

Look up another city

Look up another condition